Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis | Future Medicinal Chemistry
Gilenya (fingolimod) - Rare Disease Advisor
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis | Semantic Scholar
Oral Therapies in MS: Changing the Care Paradigm (Transcript)
Molecular mechanism of Fingolimod as a functional antagonist for S1P... | Download Scientific Diagram
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system - Brinkmann - 2009 - British Journal of Pharmacology - Wiley Online Library
Fingolimod for Multiple Sclerosis | NEJM
Sphingosine-1-phosphate Receptor Modulators in Multiple Sclerosis | touchNEUROLOGY
Fingolimod is a potential novel therapy for multiple sclerosis | Nature Reviews Neurology
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect
Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy - ScienceDirect
Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis: Molecular Therapy
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy - Journal of the Neurological Sciences
Emerging multiple sclerosis oral therapies | Neurology
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis | SpringerLink
Fingolimod - Novel Therapy for Multiple Sclerosis - Clinical Trials Arena
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis | Semantic Scholar
A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine
More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect
Simplified overview of postulated mechanism of action of standard... | Download Scientific Diagram
Action mechanism of fingolimod and other S1P receptor modulators.... | Download Scientific Diagram
Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement - ScienceDirect
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation | Journal of Neuroinflammation | Full Text
Emerging multiple sclerosis oral therapies | Semantic Scholar
Fingolimod
Mechanism of action of Fingolimod | Download Scientific Diagram
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
